404 related articles for article (PubMed ID: 33917022)
1. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
Di Fiore R; Suleiman S; Pentimalli F; O'Toole SA; O'Leary JJ; Ward MP; Conlon NT; Sabol M; Ozretić P; Erson-Bensan AE; Reed N; Giordano A; Herrington CS; Calleja-Agius J
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917022
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in gynecological cancers: Small molecules with big implications.
Srivastava SK; Ahmad A; Zubair H; Miree O; Singh S; Rocconi RP; Scalici J; Singh AP
Cancer Lett; 2017 Oct; 407():123-138. PubMed ID: 28549791
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs related to angiogenesis in gynecological cancer.
Rahimian N; Razavi ZS; Aslanbeigi F; Mirkhabbaz AM; Piroozmand H; Shahrzad MK; Hamblin MR; Mirzaei H
Gynecol Oncol; 2021 Jun; 161(3):896-912. PubMed ID: 33781555
[TBL] [Abstract][Full Text] [Related]
5. Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.
Traver S; Assou S; Scalici E; Haouzi D; Al-Edani T; Belloc S; Hamamah S
Hum Reprod Update; 2014; 20(6):905-23. PubMed ID: 24973359
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in glycolysis in gynecological tumors (Review).
Chen Q; Shen S; Lv N; Tong J
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052244
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA and gynecological cancers: Focus on miR-195.
Davoodvandi A; Rafiyan M; Mansournia MA; Rajabpoor Nikoo N; Saati M; Samimi M; Asemi Z
Pathol Res Pract; 2023 Sep; 249():154784. PubMed ID: 37639954
[TBL] [Abstract][Full Text] [Related]
9. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
[TBL] [Abstract][Full Text] [Related]
10. Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis.
Precazzini F; Detassis S; Imperatori AS; Denti MA; Campomenosi P
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503982
[TBL] [Abstract][Full Text] [Related]
11. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs Role in Prostate Cancer.
Balacescu O; Dumitrescu RG; Marian C
Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in the thyroid.
Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
[TBL] [Abstract][Full Text] [Related]
14. Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021.
Zhang C; Sun C; Zhao Y; Wang Q; Guo J; Ye B; Yu G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232692
[TBL] [Abstract][Full Text] [Related]
15. Implications of microRNA dysregulation in the development of prostate cancer.
Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
[TBL] [Abstract][Full Text] [Related]
16. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.
O'Brien J; Hayder H; Zayed Y; Peng C
Front Endocrinol (Lausanne); 2018; 9():402. PubMed ID: 30123182
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC
Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193
[TBL] [Abstract][Full Text] [Related]
18. Genetic alteration regulated by microRNAs in biliary tract cancers.
Wang N; Xia S; Chen K; Xiang X; Zhu A
Crit Rev Oncol Hematol; 2015 Nov; 96(2):262-73. PubMed ID: 26095617
[TBL] [Abstract][Full Text] [Related]
19. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs: Key Players in Bladder Cancer.
Li Q; Wang H; Peng H; Huang Q; Huyan T; Huang Q; Yang H; Shi J
Mol Diagn Ther; 2019 Oct; 23(5):579-601. PubMed ID: 31325035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
